Skip to main content
Journal ArticleOPEN ACCESS

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol

  • Zhu Z
  • Zhang K
  • Cai N
  • et al.
Cochrane Database of Systematic Reviews (2019)
DOI: 10.1002/14651858.cd013364
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors in people with stage I to III NSCLC who receive surgery or radiotherapy with curative intent.

Cite

CITATION STYLE

APA

Zhu, Z., Zhang, K., Cai, N., Charbek, E., Miller, A. C., Zhu, S., … Song, H. (2019). Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd013364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free